secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2024-07-18T23:59:59+00:00
Accession:  0001493152-24-028359
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen Therapeutics Advances $1.25 Million to Marizyme via Promissory Note at 18% Interest
--------------------------------------------------------------------------------

- Qualigen advanced $1,250,000 to Marizyme, Inc. on July 15, 2024, under a demand promissory note dated July 12, 2024.
- The note bears interest at 18% per annum and allows prepayment without premium or penalty.
- The agreement is disclosed under Item 1.01 of Form 8-K filed July 18, 2024, signed by CEO Michael S. Poirier.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000149315224028359/0001493152-24-028359-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000149315224028359/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-028359

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer